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Abstract: We introduce guanidinium-containing synthetic polymers based on polyguanidino-oxanorbornenes
(PGONs) as anion transporters in lipid bilayers that can be activated and inactivated by chemical stimulation.
According to ﬂuorogenic anion export experiments with vesicles, PGON transporters are most active in
neutral bilayers near their phase transition, with EC50’s in the nanomolar range. Six times higher effective
transporter concentrations were measured with aminonaphthalene-1,3,6-trisulfonate than with 5(6)-
carboxyﬂuorescein, demonstrating the importance of anion binding for transport and excluding nonspeciﬁc
efﬂux. Negative surface potentials efﬁciently annihilate transport activity, while inside-negative membrane
potentials slightly increase it. These trends demonstrate the functional importance of counterions to hinder
the binding of hydrophilic counterions and to minimize the global positive charge of the transporter-counterion
complexes. Strong, nonlinear increases in activity with polymer length reveal a signiﬁcant polymer effect.
Overall, the characteristics of PGONs do not match those of similar systems (for example, polyarginine)
and hint toward an interesting mode of action, clearly different from nonspeciﬁc leakage caused by
detergents. The activity of PGONs increases in the presence of amphiphilic anions such as pyrenebutyrate
(EC50 ) 70 µM), while several other amphiphilic anions tested were inactive. PGONs are efﬁciently
inactivated by numerous hydrophilic anions including ATP (IC50 ) 150 µM), ADP (IC50 ) 460 µM), heparin
(IC50 ) 1.0 µM), phytate (IC50 ) 0.4 µM), and CB hydrazide (IC50 ) 26 µM). The compatibility of this broad
responsiveness with multicomponent sensing in complex matrices is discussed and illustrated with lactate
sensing in sour milk. The PGON lactate sensor operates together with lactate oxidase as a speciﬁc signal
generator and CB hydrazide as an ampliﬁer for covalent capture of the pyruvate product as CB hydrazone
(IC50 ) 1.5 µM).
Introduction
The activity of guanidinium-rich oligomers and polymers in
biomembranes has attracted much scientiﬁc attention because
of their biological importance and their complex behavior. In
biology, these oligomers are usually arginine-rich peptides or
proteins, such as heptaarginine R7 or polyarginine R72 (Figure
1). Prominent examples of arginine-rich proteins and their
intriguing biomembrane activities include cell-penetrating pep-
tides (CPPs),
1–4 such as HIV-TAT and many synthetic mimics,
1
the voltage sensors of potassium channels,
2–5 and synthetic
multifunctional pores.
6 The unique properties of arginine-rich
oligo/polymers have made it difﬁcult to understand their
behavior on the molecular level, and as a result, these
phenomena have sometimes been referred to informally as
“arginine magic”. Today, there is increasing evidence that the
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much of this arginine magic.
2–5 The functional relevance of
counterions originates in the weak acidity of the guanidinium
group of the arginine side chain. Reduction of the pKa to
minimize charge repulsion by release of a proton, as in the more
acidic ammonium-containing oligomers of lysine, is thus not
possible for arginine-rich oligomers. As a result, tight binding
of counterions remains as the only solution to compensate for
the excess of positive charge.
Understanding the functional role of the resulting complexes
is challenging because they are not only thermodynamically
stable but also kinetically labile. This ability to rapidly exchange
tightly bound counterions makes arginine-rich peptides and
proteins exceptionally adaptable to many different environments.
For example, to easily translocate across cell membranes, CPPs
exchange their hydrophilic counterions with amphiphilic coun-
terions to move across the bilayer membrane and then pick up
their hydrophilic counterions again on the other side to exit the
membrane.
2–4 The same concept of counterion-mediated func-
tion has been more recently suggested to account for the voltage
gating of potassium channels with arginine-rich sensors.
5 Based
on this model of the interplay between the lipid bilayer
membrane, the guanidinium group, and the counterions, new
functions of CPPs have been successfully produced in a rational
manner. Examples include rapid cytosolic delivery of CPPs with
counterion additives
2–4 and CPPs that can detect the activity of
hyaluronidase inhibitors, which are potential targets for drug
discovery.
7
The ability to design simpler synthetic polymers that capture
the biological activity of natural peptides remains an important
scientiﬁc endeavor. Over the past few years, extensive effort
has focused on synthetic mimics of antimicrobial peptides
(SMAMPs).
8–10 These SMAMPs have focused almost exclu-
sively on polycationic amine rather than guanidinium function-
ality. Expanding the range of peptide activity that can be
successfully mimicked will enable new insight and potentially
new opportunities for medical therapies, sensors, etc.
11
Herein, we introduce synthetic guanidinium-rich polymers
that, compared to polyarginine, are more hydrophobic and
have a more shape-persistent scaffold, namely polyguanidino-
oxanorbornene (PGON) transporters. We provide an extensive
characterization of their membrane activity, including the
dependence on pH, concentration, length, membrane ﬂuidity,
membrane potential, and surface potential. The global
responsiveness of these transporters reveals signiﬁcant dif-
ferences when compared with similar systems. Their overall
ability to respond to chemical stimulation by both activation
and inactivation is similar to that of CPPs, although PGONs
show different selectivities than CPPs. These ﬁndings imply
that PGON-counterion complexes could act as multicom-
ponent sensors in complex matrices,
12 a promising application
of membrane transporters
13 that attracts current scientiﬁc
attention but has so far been limited to synthetic multifunc-
tional pores.
14,15 Lactate sensing in milk, with lactate oxidase
for signal generation and Cascade Blue (CB) hydrazide for
signal ampliﬁcation,
15 is used to demonstrate their potential
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Figure 1. Structure of polyguanidino-oxanorbornenes (PGONs) N and cell-
penetrating peptides (CPPs) R used in this study. All PGONs are mixtures
of cis- and trans-alkenes and were prepared as TFA salts (X ) CF3COO
-).
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easily accessible membrane transporter, which complements




Design and Synthesis. CPPs have been recently introduced
as a readily available substitute for some sensing applications
with synthetic multifunctional pores.
7 Similarly, PGON trans-
porters can be synthesized in a less-demanding and straight-
forward manner (Scheme 1). The oxanorbornene compound 1
9h
was guanidinylated in good yield to afford monomer 2, which
smoothly undergoes ring-opening metathesis polymerization
(ROMP) using the third-generation Grubbs catalyst at room
temperature in CH2Cl2. The degree of polymerization (DP) was
controlled by varying the monomer-to-catalyst ratio, and the
resulting Boc-protected polymers gave polydispersity indices
(PDIs) between 1.05 and 1.40, based on GPC (polystyrene-
calibrated) in THF. Once deprotected, these guanidinium-based
PGON transporters were dissolved in water, ﬁltered (0.45 µm
pore), and then freeze-dried to afford soft pale solids which are
readily soluble in buffer solutions.
16
Activity. The activity of PGONs as well as their respon-
siveness to physical and chemical stimulation was determined
in ﬂuorogenic vesicle assays.
13–17 8-Aminonaphthalene-1,3,6-
trisulfonate (ANTS) and 5(6)-carboxyﬂuorescein (CF) were
used as ﬂuorescent probes in egg yolk phosphatidylcholine
(EYPC) large unilamellar vesicles (LUVs), thus yielding
EYPC-LUVs⊃ANTS/DPX when loaded with ANTS and the
quencher p-xylene-bis-pyridinium bromide (DPX), or EYPC-
LUVs⊃CF when loaded with CF. In the ANTS/DPX assay,
membrane activity is observed as an increase in ANTS
emission due to the export of the cationic quencher DPX,
the anionic ﬂuorophore ANTS, or both from the vesicle and
subsequent dilution into the surrounding media. In the similar
CF assay, an increase in CF emission during CF export occurs
because of the decrease in CF self-quenching upon dilution.
The CF assay is more attractive for sensing, because of its
higher sensitivity, whereas the ANTS/DPX assay is more
attractive for characterization, because it is less dependent
on pH and on the ion and size selectivity of the membrane
transporters.
17
The activity of PGON transporters increased with increasing
concentration at constant vesicle concentration, as shown in
Figure 2. From these curves, Hill plots were determined for
the PGON transporters.
16–18 The obtained Hill plots revealed a
nonlinear dependence of the fractional activity Y on the
concentration c of monomeric macromolecules (Figure 3). Hill
analysis using eq 1,
Y∝ (c⁄EC50)
n (1)
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Scheme 1. Synthesis of PGON Polymers N
a
a Reagents and conditions: (a) TFA, CH2Cl2, 2 h, rt, quant. (b) N,N′ -
Di-Boc-1H-pyrazole-1-carboxamidine, TEA, (90% CH3CN, 10% H2O), 2 h,
rt. (c) Grubbs catalyst, CH2Cl2, 0.5-2 h, rt. (d) TFA, CH2Cl2, 4 h, rt, quant.
Figure 2. Dependence of transmembrane activity on the concentration of
N41. Fractional CF emission intensity IF (λex ) 492 nm, λem ) 517 nm) is
shown during the addition of N41 (1 nM to 10 µM ﬁnal concentration) to
EYPC-LUVs⊃CF (50 mM CF, 10 mM Tris, 100 mM NaCl, pH 7.5, 25
°C, calibrated by ﬁnal addition of Triton X-100).
Figure 3. (A) Hill plot of PGONs N5 (b), N14 (9), N37 (O), and N41
(0) in CF vesicles with ﬁt to eq 1. (B) EC50’s of N5, N14, N37, and N41
as a function of polymer length, i.e., the average number N of monomers
per polymer, with ﬁt to eq 2. Fractional activity Y compares fractional
emissions IF at given time after addition of the transporter (here 200 s after
the start of the transport experiment; see Figure 2 for changes of IF with
time).
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the concentrations needed to observe 50% activity. The con-
sistently found Hill coefﬁcients of 1 < n < 2 revealed relatively
poor cooperativity, although it cannot be excluded that the active
transporter may consist of more than one monomer, and that
the assembly of this active supramolecule is endergonic.
17,18
Nevertheless, the EC50’s decreased in a clearly nonlinear
manner with polymer length (Figure 3B), and analyzing the data
according to eq 2,
EC50∝ N
-p (2)
revealed a quite remarkable polymer effect
19 (p ) 1.78) that
extended well beyond hydrophobic matching of polymer length
and membrane thickness.
20 The EC50 of the longest N41 was
clearly better than expected from eq 2. The origin of this
exception could be traced back to the high PDI ) 1.40 of N41
compared to the shorter polymers with PDI e 1.10 (Figure 1).
The unusually high activity of N41 thus originated presumably
from the longer polymers in the less homogeneous mixture. For
comparison, heptaarginine R7 and polyarginine R72 were
inactive under these conditions without counterion activation
(see below).
3
Clearly higher EC50’s were obtained with the ANTS/DPX
assay in EYPC vesicles. For example, the EC50 ) 0.46 (
0.04 µMo fN14 in CF vesicles increased 6 times to EC50 )
2.8 ( 0.3 µM in ANTS/DPX vesicles. This dependence of
transporter activity on the assay system was in support of
speciﬁc anion transport and disfavored nonspeciﬁc anion
leakage through major membrane defects. The lower activity
with ANTS compared to CF was consistent with weaker
binding of dianionic ANTS compared to trianionic CF to the
polyguanidino transporter.
The pH proﬁle of PGON transporters was obtained by
adjusting the pH in the outside buffer. Increasing activity with
increasing pH was observed with the CF and the ANTS assay.
Both assays showed similar, slightly sigmoidal proﬁles, with
the strongest increases occurring around pH 7.5 (Figure 4A).
The observed independence on the assay system (CF or ANTS/
DPX) ruled out that different protonation states of the ﬂuorescent
probes are responsible for the observed pH dependence. Far
below the pKa ≈ 12.5 of guanidinium cations,
2–4 contributions
from PGON deprotonation can also be readily excluded, even
considering proximity effects. Most likely, ﬂuorophore/OH
-
antiport is responsible for the observed pH dependence, with
rate-limiting steps being OH
- import below and ﬂuorophore
export above pH 7.5. This interpretation supports the postulated
importance of anion binding. Similar interpretations could be
formulated for phosphates as functional counterions (scavenged
from the environment).
2–4,6a
The dependence of the activity of PGON transporters on
membrane ﬂuidity was determined in dipalmitoyl phosphatidyl-
choline (DPPC) vesicles. This is a common choice because the
transition from gel to liquid-crystalline phase of DPPC vesicles
occurs conveniently at 41 °C.
3,21 The highest activity of PGONs
was found around the phase transition (Figure 4B). This behavior
is different from that of CPP-counterion complexes
3 and many
other synthetic and biological carriers, channels, and pores,
13 which
are consistently most active in the ﬂuid phase. Maximal activity
located outside the ﬂuid phase indicated that partitioning into the
membrane does not limit activity.
17,22,23 Maximal activity located
around the phase transition rather suggested that intermediate
phases, such as the “ripple” phase, the membrane heterogeneity,
or membrane defects that occur under these conditions, are
important for activity.
21 The activity around the phase transition
temperature in DPPC vesicles was comparable to that in the liquid
phase in EYPC vesicles.
The dependence of the activity of PGON transporters on negative
surface potentials was determined in mixed vesicles composed of
neutral EYPC and anionic EYPG (phosphatidylglycerol).
2–4,23b The
presence of just 10% of EYPG in EYPC vesicles was sufﬁcient to
cleanly annihilate the activity of PGON transporters (Figure 5A).
This behavior contrasts that of polyarginine, which is inactive in
neutral EYPC vesicles without further additives but becomes highly
(19) (a) Baldini, L.; Casnati, A.; Sansone, F.; Ungaro, R. Chem. Soc. ReV.
2007, 36, 254–266. (b) Crespo-Biel, O.; Ravoo, B. J.; Reinhoudt,
D. N.; Huskens, J. J. Mater. Chem. 2006, 16, 3997–4021. (c) Stone,
M. T.; Heemstra, J. M.; Moore, J. S. Acc. Chem. Res. 2006, 39, 11–
20. (d) Badjic, J. D.; Nelson, A.; Cantrill, S. J.; Turnbull, W. B.;
Stoddart, J. F. Acc. Chem. Res. 2005, 38, 723–732. (e) Das, G.; Matile,
S. Chirality 2001, 13, 170–176. (f) Kiessling, L. L.; Strong, L. E.;
Gestwicki, J. E. Annu. Rep. Med. Chem. 2000, 35, 321–330. (g) Ariga,
K.; Kunitake, T. Acc. Chem. Res. 1998, 31, 371–378. (h) Mammen,
M.; Choi, S. K.; Whitesides, G. M. Angew. Chem., Int. Ed. 1998, 37,
2755–2794. (i) Sakai, N.; Brennan, K. C.; Weiss, L. A.; Matile, S.
J. Am. Chem. Soc. 1997, 119, 8726–8727.
(20) (a) Matile, S. Chem. Rec. 2001, 1, 162–172. (b) Ghebremariam, B.;
Sidorov, V.; Matile, S. Tetrahedron Lett. 1999, 40, 1445–1448. (c)
Ni, C.; Matile, S. Chem. Commun. 1998, 33, 755–756.
(21) Yeagle, P. The Structure of Biological Membranes; CRC Press: Boca
Raton, FL, 1992.
(22) Sakai, N.; Matile, S. Chem. BiodiV. 2004, 1, 28–43.
(23) (a) Sakai, N.; Gerard, D.; Matile, S. J. Am. Chem. Soc. 2001, 123,
2517–2524. (b) Sakai, N.; Houdebert, D.; Matile, S. Chem. Eur. J.
2003, 9, 223–232.
Figure 4. Dependence of PGON activity on (A) pH and (B) membrane
ﬂuidity. (A) pH proﬁle of N14 (O, 0) and N41 (b, 9) in EYPC vesicles
loaded with CF (O, b) or ANTS/DPX (0, 9). (B) Dependence of N14
activity in DPPC vesicles on temperature (CF, pH 7.5).
Figure 5. Dependence of PGON activity on (A) surface and (B) membrane
potential. (A) Dependence of activity Y of N14 on the mole fraction of
EYPG in EYPC/EYPG-LUVs⊃ANTS/DPX. (B) Dependence of the initial
velocity of change in emission of ANTS after addition of N14 [1 µM( O)
and 10 µM( b) ﬁnal] to EYPC-LUVs⊃ANTS/DPX with valinomycin (0.6
µM), 100 mM internal KCl, and variable mixtures of iso-osmolar external
KCl and NaCl.
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2
Inactivation in anionic vesicles has, however, been observed for
the lysine-rich pore melittin and for lysine-rich synthetic multi-
functional pores.
2,23,24 While the latter showed less dramatic
responses to the surface potential,
23 the response of melittin
occurred in the same lipid ratio range (∼10%) and was similarly
intense.
2,23,24 The clear-cut inactivation of CF export by anionic
lipids suggested that efﬁcient multivalent binding of the cationic
amphiphilic transporter to these anionic amphiphilic lipids may
hinder counteranion exchange with hydrophilic anions. This
interpretation was in agreement with results from the pH depen-
dence and the dependence of Hill plots on the assay system (i.e.,
CF versus ANTS export). Inactivation by hydrophobic counterions
conﬁrmed that anion binding to and anion hopping along the
polycationic transporter is essential for function. This behavior is
clearly different from that of the more hydrophilic CPPs, which
require hydrophobic counterion activators such as EYPG
2 to enable
rather than inhibit the same anion-hopping mechanism across the
lipid bilayer membrane.
To determine the dependence of the activity of PGONs on
membrane potentials in EYPC vesicles, an inside-negative
Nernst potential was applied.
22,23 To do so, the K
+ carrier
valinomycin was added to vesicles with a transmembrane
potassium gradient at concentrations high enough to produce a
current but small enough to avoid immediate gradient collapse.
Anion export and membrane potential were monitored simul-
taneously by double-channel experiments with internal ANTS
(λexc ) 353 nm, λem ) 510 nm) and external safranin O (λexc )
522 nm, λem ) 580 nm), respectively.
The dependence of anion transport with PGONs on the applied
membrane potential was relatively weak (Figure 5B). The strongest
changes were found for the initial rates of ANTS efﬂux at high
concentrations of N14. This dependence was almost ohmic, clearly
different from the non-ohmic behavior of biological (melittin, gating
charge zg ≈ 1.2) and lysine-rich synthetic pores (zg ≈ 0.85).
23
Although only a weak dependence on the applied membrane
potential was expected for a molecule lacking a permanent axial
dipole moment,
23 inside-negative polarization should increase
partitioning of cationic transporters into the lipid bilayer membrane.
The observed relatively weak voltage sensitivity thus suggested
that the positive charge of PGON transporters is counterbalanced
by multiple counterion complexation (for example, with OH
-,a s
suggestedfromthepHdependence),resultingintransporter-counter-
ion complexes with only weak positive total charge in solution.
This ﬁnding supported the above-outlined model of thermodynami-
cally stable but kinetically labile complexes and was in agreement
with the results from surface potentials and Hill plots for CF versus
ANTS.
Activators. The responsiveness of PGON transporters to
activation was evaluated using the least active oligomer, N5.
From the known
3 collection of amphiphilic counterion activators
(Figure 6), only pyrenebutyrate 6 worked. Other amphiphilic
counterions that were tested failed to activate N5. Examples
include the homologous pyreneacetate 7 and pyrenehexanoate
8, sodium dodecyl sulfate (SDS), sodium octyl sulfate (SOS),
dodecyl phosphate, and cholate. The general role of amphiphilic
counterion activators to increase binding to and accelerate the
translocation across intact lipid bilayers is likely to apply to
the activation of N5 by pyrenebutyrate as well. With activity
found for all pyrene homologues (7,E C 50 ) 86 ( 3 µM; 6,
EC50 ) 44 ( 2 µM; 8,E C 50 ) 9.3 ( 0.7 µM), counterion
activation of CPPs in EYPC vesicles was clearly less selective
than with PGONs.
3
The ﬂuorescence spectra of pyrenebutyrate-PGON com-
plexes in neutral water exhibited excimer emission similar to
that of pyrenebutyrate-polyarginine complexes (and different
from that of pyrenebutyrate-polylysine complexes).
2 For
increasing PGON concentrations, the excimer emission appeared
with an EC50 ) 2.3 ( 0.1 µM per polymer (94 µM per
monomer) for N41. The EC50 ) 4.9 ( 0.3 µM (per polymer;
69 µM per monomer) for N14 was very similar to and only
slightly higher than that for polyarginine R72 under these
conditions (EC50 ) 0.7 ( 0.1 µM per polymer; 50 µM per
monomer). The excimer emission decreased at higher polymer
concentrations, presumably because of dilution of the bound
pyrenebutyrates on the polymer backbone.
16
Pyrenebutyrate was previously found to be the best to mediate
CPP delivery to the cytosol.
4d A combination of favorable
activator-transporter and activator-membrane interactions, i.e.,
arene-templated ion pairing,
25 preferable binding at the mem-
brane interface,
26 or matching lengths of lipid and activator,
has been considered to account for the unique properties of
pyrenebutyrate as activator.
2–4 However, the precise origin of
certain exceptional properties of pyrenebutyrate as counterion
activator, such as the selectivity of PGON activation, are
unknown. Structural studies to investigate pyrenebutyrate-oligo-
guanidinium complexes in water and in bulk and lipid bilayer
membranes on the molecular level are ongoing.
Pyrenebutyrate 6 activated PGON N5 with an EC50 ) 70 (
4 µM (Figure 7A, O). The dependence on the sequence of
addition was not very pronounced. Reversal from the routine
sequence activator-vesicles-transporter to the sequence
transporter-vesicles-activator gave an EC50 ) 40 ( 6 µM with
clearly reduced cooperativity (Figure 7A, b). This activator
efﬁciency was in the range of the EC50 ) 44 ( 2 µM reported
4
for the activation of polyarginine R72 with pyrenebutyrate 6
(24) Zhang, J.; Jing, B.; Tokutake, N.; Regen, S. L. J. Am. Chem. Soc.
2004, 126, 10856–10857.
(25) Thompson, S. E.; Smithrud, D. B. J. Am. Chem. Soc. 2002, 124, 442–
449.
Figure 6. Structure of selected counteranion activators (top) and inactivators
(bottom) for PGON and/or CPP transporters.
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EC50 ) 197 ( 8 µM (Figure 7A, 0).
Inactivators. The possibility to inactivate PGON transporters
was investigated with the polymers N14 and N41, which had
intermediate and high activity, respectively (Figure 3). Hydrophilic
counterion inactivators were selected depending on their usefulness
in potential sensing applications.
14,15 ATP and ADP are important
co-substrates that can be used in a very general manner to report
on analytes that are compatible with signal generation by ATP-
dependent enzymes. To take a simple example, the concentration
of acetate in samples from the supermarket, such as rice vinegar,
has been detected quantitatively by incubation with acetate kinase
for selective signal generation and detection of the conversion of
ATP into ADP with general optical signal transducers such as
synthetic pores.
15 For this application, the signal transducer must
be sufﬁciently sensitive to detect the presence of the ATP or ADP
and must be able to discriminate ATP and ADP with a discrimina-
tion factor D as large as possible, but at least D ) 3.
14,15 The
inactivation of N14 by both nucleotides occurred at very similar
and rather high concentrations (Table 1, entries 1 and 2). With
N41, the selectivity improved to D ) 3( D ) IC50
ADP/IC50
ATP).
This is sufﬁcient for an enzyme assay but not for sensing in
complex matrices,
7 and the relatively high IC50 ) 150 µM clearly
limits practical usefulness. The same is true for R72 with
dodecylphosphate as counterion activator, which has IC50
ATP )
430 µM and D ) 4.
7 Only synthetic pores stand out so far in this
regard, with performance as good as IC50
ATP ) 1.2 µM and D )
15.
14,15
Heparin, a biologically important and chemically unique
glycosaminoglycan that is widely used as an anticoagulant drug,
inactivated both short and long PGONs N14 and N41 with
excellent sensitivities in the low micromolar range, as expected
on the basis of results with CPP-counterion complexes
2–4,7 and
synthetic pores.
27 Comparison with a commercially available
low-molecular-weight analogue, corresponding to a pentamer
of disaccharide units, revealed that N14 was capable of
discriminating the low- and high-molecular-weight heparin with
D ) 2 (Table 1, entries 3 and 4). Taking into account that the
three isoforms of heparinase commonly lead to further degrada-
tion down to disaccharide units, it is not unlikely that a simple
heparinase assay could be developed, similar to the recently
reported hyaluronidase assay with CPPs.
7
Phytate (or inositol hexaphosphate, IP6) is an analyte of
importance with regard to the phosphate crisis and the sensing
of the elusive IP7.
14b Phytate inactivated PGON transporters in
a length-dependent manner (Table 1, entry 5). The best IC50 )
400 nM obtained with N41 was clearly better than that obtained
with R72 (IC50 ) 5.4 µM) but not as good as that obtained
with synthetic pores (IC50 ) 45 nM).
14b
CB hydrazide 9 (Figure 6) is an important inactivator
because it can serve as a reactive ampliﬁer in sensing
applications.
15 For example, to sense lactate in complex
matrices, lactate oxidase is available as a speciﬁc signal
generator, and the otherwise elusive product pyruvate can
be covalently captured by hydrazide 9, to give hydrazone
10 (Scheme 2). Lactate sensing thus requires the detection
of hydrazone 10 without interference from hydrazide 9.
PGON transducers responded to 9 and 10 depending on the
polymer length (Table 1, entries 6 and 7). Increasing
sensitivity naturally coincided with decreasing selectivity.
N14, with D ) 17 at IC50 ) 1.5 µM, exceeded synthetic
pores in terms of selectivity (D ) 8.8, IC50 ) 2.6 µM) at
comparable sensitivity,
15 while N41 was even more sensitive
at a comparable selectivity (D ) 6.8, IC50 ) 0.4 µM).
Similarly promising results were obtained for CB ketoglut-
arate 11 (D ) 26, IC50 ) 1.0 µM for N14; D ) 9, IC50 )
0.29 µM for N41), which is important for glutamate sensing.
15
The π-basic dialkoxynaphthalene (DAN) ampliﬁers have
been introduced for efﬁcient inactivation of π-acidic synthetic
pores by “adhesive π-clamping” with operational aromatic
electron donor-acceptor (AEDA) interactions.
15 Applied to
PGON transporters, DAN pyruvate 12 was essentially unable
Figure 7. (A) Activation and (B) inactivation of PGON transporters. (A)
Dependence of the anion transport activity of N5 (O, b) and R7 (0)o nt h e
concentration of pyrenebutyrate 6, with sequence of addition being
activator-vesicles-transporter (O, 0) or transporter-vesicles-activator
(b). (B) Dependence of the activity of N14 on the concentration of CB
hydrazide 9 (O) and CB pyruvate 10 (b).






1 ATP 500 ( 100 150 ( 60
2 ADP 560 ( 140 460 ( 30
3 heparin 1.4 ( 0.1
e 1.3 ( 0.1
e
4 heparin (low MW)
d 3.2 ( 0.3
e 1.0 ( 0.1
e
5 phytate 14 ( 3 0.4 ( 0.2
6 CB hydrazide 9 26 ( 6 2.7 ( 0.7
7 CB pyruvate 10 1.5 ( 0.1 0.4 ( 0.1
8 CB ketoglutarate 11 1.0 ( 0.1 0.3 ( 0.04
9 DAN pyruvate 12 >200 36 ( 4
a Determined from dose-response curves for ﬂuorogenic CF export
from EYPC-LUVs⊃CF as in Figure 7B.
b See Figure 6; ATP, adenosine
5′ -triphosphate; ADP, adenosine 5′ -diphosphate.
c Inactivator concen-
tration required for 50% inactivation of N14 or N41 (Figure 1), data (
SE.
d MW, molecular weight; obtained by peroxidolysis from heparin,
average MW ) 3000 g/mol.
e Based on an assumed molecular weight of
573.4 g/mol for the monomer, corresponding to a disaccharide
composed of 2-O-sulfo-R-L-iduronic acid and R-D-N-sulfogluco-
samine-6-O-sulfate.
Scheme 2. Reaction Scheme for Lactate Sensing with Lactate
Oxidase as Signal Generator and Hydrazide 9 as Reactive Signal
Ampliﬁer for Detection of the Otherwise Elusive Product Pyruvate
as Hydrazone 10
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36 µM obtained for inactivation of N41 was still 2.6 times
higher than that obtained with synthetic pores (IC50 ) 14
µM).
15 As the formal monomer charge of π-acidic synthetic
pores is 8+, these ﬁndings suggested that inactivation of
synthetic pores by π-clamping with speciﬁc AEDA interac-
tions is much more powerful than inactivation of PGON
transporters by multi-ion pairing.
Detection of Enzyme Activity. To provide a meaningful
example, the discrimination of CB hydrazide 9 and CB pyruvate
10 was selected to demonstrate the ability of PGON transporters
to detect the activity of enzymes (Scheme 2).
14,15,27 The previously
reported method was used with minor modiﬁcations.
15 In brief,
lactate was ﬁrst incubated with lactate oxidase and catalase to
remove interference from hydrogen peroxide. To follow the
conversion of lactate into pyruvate, aliquots were taken from the
reaction mixture at meaningful intervals and incubated with CB
hydrazide ampliﬁer 9. An aliquot of the obtained reaction mixture
was then added to EYPC vesicles, and the appearance of
ﬂuorescence in response to the addition of N14 was monitored.
Decreasing ﬂuorescence with increasing incubation time revealed
the time course of the conversion of lactate into pyruvate, the latter
being detected as inactivation of N14 because hydrazone 10
inactivates better than hydrazide 9 (Scheme 2 and Figure 8A). The
dependence of the reaction kinetics on the presence and the
concentration of lactate oxidase demonstrated that N14 indeed
detects the activity of the enzyme.
Sensing in Complex Matrices. The ability of PGON transporters
to act as optical signal transducers in sensing applications
14,15 was
demonstrated with lactate oxidase as a signal generator and CB
hydrazide 9as signal ampliﬁer. Following the procedures elaborated
with synthetic pores,
15 milk serum was incubated ﬁrst with lactate
oxidase and then with ampliﬁer 9, and the effective volume of the
obtained mixture to inactivate N14 was determined (Figure 8B).
Comparison of the obtained value with calibration curves multiplied
with all dilution factors gave a lactate concentration of 72.2 mM
in sour milk. This value was in the range determined previously
with synthetic pores




The activity of polyguanidino-oxanorbornenes (PGONs) as
anion transporters in lipid bilayers has been characterized with
regard to the dependence on polymer length and concentration,
pH, membrane ﬂuidity, and surface and membrane potentials.
Moreover, the responsiveness to amphiphilic counterion activa-
tors and hydrophilic counterion inactivators has been identiﬁed,
characterized, and applied to the detection of enzyme activity
and the sensing in complex matrices.
Comparison of the results with those obtained for similar
systems, such as CPP-counterion complexes
2–4,7 and synthetic
pores,
6,14,15,23,27 reveals clear differences, with some advantages
and some disadvantages. The nonlinear increase of activity with
polymer length provides a high membrane activity that can be
obtained without counterion activators and much synthetic effort.
However, the low micromolar EC50’s achieved with PGONs are
not in the range of activity of advanced synthetic pores. Different
Hill plots for CF and ANTS transport, weak activation by
membrane potentials, and strong inactivation by surface potentials
all highlight the functional importance of speciﬁc anion exchange
on and dynamic anion hopping along the polycationic polymer for
transport and disfavor the existence of nonspeciﬁc leaks. Some
characteristics, such as high activity around the phase transition
and rapid inactivation by surface potentials, are clearly different
from those of CPP-counterion carriers and point toward the
occurrence of a distinct, interesting mechanism of action.
The general responsiveness of a guanidinium-rich anion trans-
porter to activators and inactivators could be expected on the basis
of extensive results with CPPs.
2–4,7 Nonetheless, the clear-cut
discrimination between homologous activators such as 6, 7, and 8
is remarkable and so far not understood. The discrimination
between CB hydrazide 9 and the corresponding hydrazones 10 and
11 is of immediate practical relevance for the detection of
enzymatic activity and for sensing in complex matrices. The latter
has been demonstrated with lactate oxidase to sense lactate in sour
milk. Compared to the more hydrophilic CPPs such as oligo/
polyarginines, the high intrinsic activity of PGONs allows reducing
the complexity of the system, although also limiting the responsive-
ness to amphiphilic anions as activators other than pyrenebutyrate.
This ﬁrst detailed report on the membrane activity of a synthetic
mimic of polyarginine shows that the overall chemical structure
and molecular backbone (more hydrophobic) can inﬂuence activity.
With the wide variety of chemical structures available to the
synthetic supramolecular chemist, it appears that synthetic
polyguanidines will prove to be interesting new structures with
strong relevance to membrane activity, sensing, molecular transport,
and even potentially therapeutics.
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Figure 8. (A) Detection of enzyme activity and (B) sensing in complex
matrices with PGON transporters. (A) Change in activity of N14 as a
function of the time of incubation of lactate with lactate oxidase (b, 2.5
units/mL; O, 0.5 units/mL; 0, 0 units/mL). Reaction mixtures were ampliﬁed
with hydrazide 9 before detection of their ability to inactivate N14. (B)
Change in activity of N14 as a function the initial volume sour milk added
after sample preparation (serum) and incubation with ﬁrst lactate oxidase
(2.5 units/mL) and then ampliﬁer 9.
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